Total AssetsCash & ST Inv.Total LiabilitiesLong-Term DebtTotal DebtShareholders EquityTotal Current AssetsTotal Current LiabilitiesReceivablesInventoryRetained Earnings
No data for this metric.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.